Introduction: Dyslipidemia and subclinical hypothyroidism are interconnected health conditions that often coexist. Subclinical hypothyroidism, characterized by slightly elevated thyroid-stimulating hormone levels, has been associated with adverse lipid profiles Objectives: To determine the frequency of dyslipidemia in patients having subclinical hypothyroidism. Study design: Cross sectional study Settings: Department of Internal Medicine, Mayo Hospital, Lahore. Study duration: From January 2023 to From June 2023. Materials & Methods: This study employed a cross-sectional observational design. The study included adult patients (aged 18 and above) diagnosed with subclinical hypothyroidism, selected from outpatient clinics and endocrinology departments. Participants with known cardiovascular diseases, diabetes, or any other conditions influencing lipid metabolism were excluded. Baseline demographic information, medical history, and thyroid function test results were obtained from medical records. Lipid profiles, including total cholesterol, LDL-C, HDL-C, and triglycerides, were measured using standardized laboratory methods. Descriptive statistics were used to summarize demographic characteristics and lipid profiles. Results: In the subclinical hypothyroidism patient group, there were 28 males (43.1%) with a mean age of 45.8 years (±7.2), a mean BMI of 27.5 kg/m² (±3.4), and 12 of them were smokers (42.9%). Additionally, there were 37 females (56.9%) with a mean age of 47.2 years (±6.5), a mean BMI of 28.3 kg/m² (±3.2), and 8 of them were smokers (21.6%). Out of the total 65 individuals, 37 (56.92%) were found to have dyslipidemia, while 28 (43.07%) did not exhibit dyslipidemia. Thus, the overall prevalence of dyslipidemia in the study population was determined to be 56.92%. Conclusion: In conclusion, our study on subclinical hypothyroidism patients demonstrated a significant prevalence of dyslipidemia at 56.92%, highlighting the association between thyroid dysfunction and altered lipid profiles.